About Itamar Medical Itamar-Medical is a pioneer in developing The PAT signal technology which provides is a non-invasive "window" to the cardiovascular and autonomic nervous system allowing the monitor and measurement of critical patient information such as sleep disorders and cardiovascular health.
Leading the field of endothelial function assessment, the EndoPAT 2000 is the only non-invasive, FDA cleared medical device that detects endothelial dysfunction making CVD treatable and reversible.
Using the patented PAT (Peripheral Arterial Tone) technology, the EndoPat provides a non-invasive window into the sympathetic nervous system and endothelial function through measuring changes in the arterial pulsatile blood volume thus providing measurement of early stage disease
With over 500 devices installed, 60,000 studies performed and over 220 publications and abstracts EndoPAT is a valuable clinical tool for cutting edge prevention and treatment of CVD.
Mission Statement Itamar Medical is dedicated to the research, development and commercialization of a wide range of medical products based on the PAT (Peripheral Arterial Tone) Technology in order to improve the quality of healthcare.
Commitment to Quality Itamar Medical is committed to delivering the highest levels of quality and customer satisfaction. At Itamar Medical quality is a priority, requiring management and employees at all levels to continuously strive for excellence and improvement.
Itamar Medical complies with international standards of quality (ISO 9001, ISO 13485).